Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DCFPyL PET/CT vs Conventional Imaging in CRPC
NCT02691169Phase 1Unknown
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Apr 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by St. Joseph's Healthcare Hamilton. Status: unknown.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02691169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691169.